Inactive

Roche Venture Fund

General contacts

Investor type

CVC

Founded

1896

AUM

$850 M

Location

Basel, Basel-Stadt, Switzerland

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Series B Late Stage (Series C+)

Region of investment

North America Europe Asia

ESG Focus

Impact investor

Investor profile last updated: 30 August, 2026

Profile

Roche Venture Fund is a corporate venture capital fund headquartered in Basel, Switzerland. It was established as the investment arm of Roche, a global healthcare company with a rich history in biotechnology and pharmaceuticals. The fund operates with a dedicated team, focused on identifying and investing in pioneering healthcare innovations. As part of a well-established pharmaceutical giant, Roche Venture Fund benefits from deep industry knowledge and a wide network of strategic partners.

The investment strategy of Roche Venture Fund primarily targets the life sciences sector, including biotechnology, pharmaceuticals, diagnostics, and personalized healthcare. They typically invest in Series A and beyond, with a global mandate that spans North America, Europe, and Asia. The fund capitalizes on the synergies with Roche's core business areas, aiming to nurture innovative science into commercial reality.

Roche Venture Fund has a diverse portfolio that includes exciting companies such as C4 Therapeutics - a biotech firm focused on degrader therapeutics, Mission Therapeutics - a company developing DUB inhibitors, and FORMA Therapeutics - known for its focus on cancer and hematologic diseases. Their investments often align with Roche's strategic interests, facilitating both financial return and strategic collaboration potential.

Industry

HealthTech Biotechnology Healthcare Services Medical Devices Pharmaceuticals Software MedTech Life Sciences

Roche Venture Fund Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Roche Venture Fund	Corporate VC (CVC)	Biotechnology Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences	Seed Series A Series B	North America	$5-10 m	$516 M	December 2002

Contacts

Name

Title

Social Networks

Monte Curnutt Vice President Corporate Development at Roche Diagnostics USA

Vice President Corporate Development at Roche Diagnostics USA

m•••@•••

Anna Williamson Executive Director & UK Partnering Lead, Pharma Partnering at Roche/Genentech

Executive Director & UK Partnering Lead, Pharma Partnering at Roche/Genentech

a•••@•••

Upgrade to see contacts

qohkPXI9DrYjuEgi qohkPXI9DrYjuEgi

qohkPXI9DrYjuEgi

[email protected]

qohkPXI9DrYjuEgi qohkPXI9DrYjuEgi

qohkPXI9DrYjuEgi

[email protected]

qohkPXI9DrYjuEgi qohkPXI9DrYjuEgi

qohkPXI9DrYjuEgi

[email protected]

Investment-team contacts for Roche Venture Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Roche Venture Fund

Is Roche Venture Fund a venture capital or private equity firm?

Roche Venture Fund operates as a corporate VC (CVC). It backs companies at Series A, Seed, Series B and Late Stage (Series C+), writing tickets of $10-50 m.

Where is Roche Venture Fund located?

Roche Venture Fund is located in Basel, Basel-Stadt, Switzerland.

When was Roche Venture Fund founded?

Roche Venture Fund was founded in 1896.

What sectors and industries does Roche Venture Fund invest in?

Roche Venture Fund invests in companies and startups in HealthTech, Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals, Software, MedTech, Life Sciences.

What is Roche Venture Fund geographical focus of investments?

Roche Venture Fund invests in companies and startups in North America, Europe, Asia.

At what stages of companies and startups does Roche Venture Fund typically invest in?

Roche Venture Fund invests in companies and startups at Series A, Seed, Series B, Late Stage (Series C+).

What is the usual amount of Roche Venture Fund investment?

Roche Venture Fund usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for Roche Venture Fund?

Roche Venture Fund has around $850m assets under management.

When was Roche Venture Fund last fund created?

Roche Venture Fund last fund was created/launched in 2002-12-17

Is Roche Venture Fund impact investor?

Yes, Roche Venture Fund is impact investor.

What are the contacts of Roche Venture Fund?

Roche Venture Fund can be reached through its website roche.com/careers, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Roche Venture Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Roche Venture Fund data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Roche Venture Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Roche Venture Fund profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 30 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.